Deals & business · first seen yesterday, updated yesterday

Roche’s acquired GLP-1/GIP normalises blood sugar in Phase II trial

1 outlet GLP-1 & obesity drugs Roche

Roche drops the data for its GLP-1/GIP as the obesity and type 2 diabetes markets continue to grow exponentially. The post Roche’s acquired GLP-1/GIP normalises blood sugar in Phase II trial appeared first on Clinical Trials Arena .

Summary from Clinical Trials Arena.

Coverage 1 article · 1 outlet

Clinical Trials Arena yesterday
Roche’s acquired GLP-1/GIP normalises blood sugar in Phase II trial